Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

170 trials with published results (14%)

Research Maturity

576 completed trials (48% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.3%

51 terminated out of 1197 trials

Success Rate

91.9%

+5.4% vs benchmark

Late-Stage Pipeline

4%

51 trials in Phase 3/4

Results Transparency

30%

170 of 576 completed with results

Key Signals

170 with results92% success51 terminated

Data Visualizations

Phase Distribution

938Total
Not Applicable (692)
Early P 1 (12)
P 1 (68)
P 2 (115)
P 3 (14)
P 4 (37)

Trial Status

Completed576
Unknown202
Recruiting192
Active Not Recruiting70
Not Yet Recruiting58
Terminated51

Trial Success Rate

91.9%

Benchmark: 86.5%

Based on 576 completed trials

Clinical Trials (1197)

Showing 20 of 20 trials
NCT07534878Phase 4Completed

Health Benefits of Nutraceutical Supplementation in Older Adults.

NCT07169630Phase 1Recruiting

PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

NCT05417555Not ApplicableRecruitingPrimary

Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease

NCT06584357RecruitingPrimary

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

NCT07521865Active Not Recruiting

Remote Technologies in Early Stages of Alzheimer's Disease

NCT03962959Not ApplicableCompletedPrimary

Enhancement of Hippocampal Plasticity Using Repetitive Transcranial Magnetic Stimulation

NCT03472664Not ApplicableRecruiting

Brain Energy for Amyloid Transformation in Alzheimer's Disease Study

NCT07012993Phase 2Recruiting

Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol

NCT02959502Not ApplicableActive Not RecruitingPrimary

Home-Based CR and tDCS to Enhance Cognition in Persons With Mild Cognitive Impairment and Late Life Depression

NCT05561205Not ApplicableRecruiting

rTMS for Apathy Clinical Trial

NCT05655325Not ApplicableRecruitingPrimary

Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity

NCT05079464Not ApplicableRecruiting

Exercise as a Primer for Brain Stimulation in Vascular Cognitive Impairment No Dementia (VCIND)

NCT05909189Not ApplicableRecruiting

LEADing Dementia End-of-Life Planning Conversations

NCT02386670Not ApplicableActive Not RecruitingPrimary

Prevention of Alzheimer's Disease With CR Plus tDCS in Mild Cognitive Impairment and Depression (PACt-MD)

NCT04583215Not ApplicableActive Not RecruitingPrimary

Enhancing Frontal Lobes Plasticity in Mild Cognitive Impairment

NCT03836950Phase 1Recruiting

rTMS to Improve Cognition in Parkinson's

NCT06867016Not ApplicableCompletedPrimary

Effects of Bidomain Cognitive and Aerobic Training on Cognitive Functioning in Mild Cognitive Impairment.

NCT05992831Not ApplicableRecruitingPrimary

Transcranial Magnetic Stimulation for MCI

NCT04199767Phase 2CompletedPrimary

SNIFF Multi-Device Study 2

NCT06916221Not ApplicableRecruiting

BID LTM Digital Intervention in Aging

Scroll to load more

Research Network

Activity Timeline